Table 2.
Classification Criteria | Sensitivity (95% CI), % | Specificity (95% CI), % | Positive Predictive Value (95% CI), % | Negative Predictive Value (95% CI), % | Accuracy (95% CI) |
---|---|---|---|---|---|
2023 ACR/EULAR APS Criteria† | 75.7 (66.6–83) | 98.8 (93.3–99.8) | 98.7 (93.2–99.8) | 76.2 (67.2–83.3) | 85.9 (80.1–90.2) |
Revised Sapporo APS Criteria† | 90.3 (83–96.6) | 91.4 (83.2–95.7) | 93 (86.2–96.6) | 88.1 (79.4–93.4) | 90.8 (85.7–94.1) |
2023 ACR/EULAR APS Criteria⁑ | 77 (67.8–84.2) | 97.6 (91.7–99.3) | 97.5 (69.3–84.9) | 78.1(69.3–84.9) | 86.4 (80.7–90.6) |
APS; antiphospholipid syndrome, CI; confidence interval.
Considering clinical evaluation by rheumatologist as the gold standard for the diagnosis of APS.
Considering the Revised Sapporo APS Criteria as the gold standard for the diagnosis of APS.